Katarzyna Tilgner

Katarzyna Tilgner has a wealth of work experience. Katarzyna began their career in 2009 as a Postdoctoral Research Assistant at Centro de Investigación Príncipe Felipe (CIPF), where they focused on optimizing the reprogramming protocol for generation of human iPSCs from difficult to reprogram somatic cell cells and comparing stress defence mechanisms and mitochondrial biogenesis regulation in hiPSC cell lines generated from adult human skin fibroblasts vs hESC lines. In 2010, they became a Postdoctoral Researcher at Newcastle University in the Lako Lab at the Institute of Genetic Medicine. From 2013 to 2019, they worked at the Wellcome Sanger Institute as a Senior Staff Scientist/Staff Scientist- Yusa Lab; Cellular Genetics, where they scientifically led, developed and performed genome wide CRISPR KO screens in human iPSCs and their pancreatic derivatives, developed reporter lines and cellular assays, and conducted hits selection and validation. Katarzyna then moved to DefiniGEN in 2019, where they currently serve as the Head of Technology Development and Senior Research Development Scientist.

Katarzyna Tilgner obtained a Bachelor of Science in Biotechnology from the University of Wroclaw between 2000 and 2003. Katarzyna then went on to earn a Master of Science in Molecular Biology from the same university between 2003 and 2005. Finally, they completed their Doctor of Philosophy in Stem Cell Biology at Newcastle University between 2005 and 2009.